P54284 (CACB3_HUMAN) Homo sapiens (Human)
Voltage-dependent L-type calcium channel subunit beta-3 UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
16 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone at 3.1 Angstrom res… |
Heteromer P54289; Q01668; | 100 | 1×NAG; 3×NAG; 1×NAG; 1×BBI; 2×CA; 1×3PE; 2×NAG; | |||
| Human L-type voltage-gated calcium channel Cav1.2 at 2.9 Angstrom resolution |
Heteromer P54289; Q13936; | 100 | 1×NAG; 3×NAG; 1×NAG; 2×CA; 1×3PE; 4×CLR; 3×NAG; 1×PT5; | |||
| Human L-type voltage-gated calcium channel Cav1.3 in the presence of cinnarizine at 3.1 Angstrom re… |
Heteromer P54289; Q01668; | 100 | 1×NAG; 3×NAG; 1×NAG; 1×N90; 3×NAG; 2×CA; 1×Y01; 1×3PE; | |||
| Human L-type voltage-gated calcium channel Cav1.2 in the presence of amiodarone and sofosbuvir at 3… |
Heteromer P54289; Q13936; | 100 | 1×NAG; 3×NAG; 1×NAG; 2×CA; 1×BBI; 1×WG6; 2×3PE; 4×CLR; 2×NAG; | |||
| P/Q type calcium channel in complex with omega-Agatoxin IVA |
Heteromer O00555; P54289; | 100 | 1×NAG; 3×NAG; 1×NAG; 3×CA; 2×NAG; 5×CLR; 1×PT5; 3×Y01; 1×3PE; | |||
| Human N-type voltage-gated calcium channel Cav2.2 in the presence of ziconotide at 3.0 Angstrom res… |
Heteromer P05484; P54289; Q00975; | 100 | 1×NAG; 3×NAG; 1×NAG; 3×NAG; 2×CA; 2×Y01; 5×CLR; 2×3PE; 1×PT5; | |||
| Human L-type voltage-gated calcium channel Cav1.2 (Class I) in the presence of pinaverium at 3.0 An… |
Heteromer P54289; Q13936; | 100 | 1×NAG; 3×NAG; 1×NAG; 2×CA; 1×3PE; 3×CLR; 3×NAG; 1×PT5; | |||
| Human L-type voltage-gated calcium channel Cav1.3 treated with 1.4 mM Sofosbuvir at 3.3 Angstrom re… |
Heteromer P54289; Q01668; | 100 | 1×NAG; 3×NAG; 1×NAG; 2×CA; 2×NAG; | |||
| Human L-type voltage-gated calcium channel Cav1.3 at 3.0 Angstrom resolution |
Heteromer P54289; Q01668; | 100 | 4×NAG; 1×NAG; 1×NAG; 2×CA; 3×CLR; 1×3PE; 2×NAG; | |||
| Human R-type voltage-gated calcium channel Cav2.3 at 3.1 Angstrom resolution |
Heteromer P54289; Q15878; | 100 | 4×NAG; 1×NAG; 2×CA; 5×CLR; 2×3PE; 1×PT5; 3×NAG; | |||
| P/Q type calcium channel in complex with omega-conotoxin MVIIC |
Heteromer O00555; P37300; P54289; | 100 | 1×NAG; 3×NAG; 1×NAG; 2×NAG; 3×CA; 5×CLR; 1×PT5; 3×Y01; 2×3PE; | |||
| P/Q type calcium channel |
Heteromer O00555; P54289; | 100 | 1×NAG; 3×NAG; 1×NAG; 1×PS1; 5×CLR; 1×PT5; 2×CA; 2×NAG; 3×Y01; 2×3PE; | |||
| Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine at 3.2 Angstrom r… |
Heteromer P22947; P54289; Q13936; | 100 | 1×NAG; 3×NAG; 1×NAG; 2×CA; 2×CLR; 3×NAG; | |||
| Human N-type voltage-gated calcium channel Cav2.2 at 3.1 Angstrom resolution |
Heteromer P54289; Q00975; | 100 | 1×NAG; 3×NAG; 1×NAG; 3×NAG; 2×CA; 3×Y01; 4×CLR; 2×3PE; 1×PT5; | |||
| Human L-type voltage-gated calcium channel Cav1.3 in the presence of Amiodarone and Sofosbuvir at 3… |
Heteromer P54289; Q01668; | 100 | 1×NAG; 3×NAG; 1×NAG; 1×BBI; 1×WG6; 2×CA; 1×NAG; | |||
| Human L-type voltage-gated calcium channel Cav1.2 in the presence of calciseptine, amlodipine and p… |
Heteromer P22947; P54289; Q13936; | 100 | 1×NAG; 3×NAG; 1×NAG; 2×CA; 5×CLR; 3×NAG; 1×PT5; 1×3PE; 1×6UB; | |||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7mix.1.D | monomer | 0.76 | 100.00 | |||
| 6hw2.1.A | monomer | 0.65 | 75.82 | |||
10 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 8e5a.1.C | monomer | 0.77 | 98.88 | |||
| Isoform 2 | 6hw2.1.A | monomer | 0.66 | 75.82 | |||
| Isoform 3 | 8e5a.1.C | monomer | 0.77 | 99.58 | |||
| Isoform 3 | 6hw2.1.A | monomer | 0.66 | 75.82 | |||
| Isoform 4 | 8e5a.1.C | monomer | 0.76 | 99.58 | |||
| Isoform 4 | 6hw2.1.A | monomer | 0.65 | 75.82 | |||
| Isoform 5 | 8e5a.1.C | monomer | 0.72 | 100.00 | |||
| Isoform 5 | 5gjv.1.B | monomer | 0.69 | 57.45 | |||
| Isoform 5 | 2d46.1.A | monomer | 0.55 | 78.18 | |||
| Isoform 5 | 6hw2.1.A | monomer | 0.55 | 77.68 | |||